Listen on the iPad edition of this issue to hear more interviews from the ASCO Annual meeting in a special edition of the Audio Journal of Oncology for OT. Download the Aug. 25 issue from the OT library of iPad issues and hear:
- Richard Carvajal on what is being called the first effective treatment for advanced melanoma of the eye.
- Volker Heinemann on his study showing that for patients with metastatic KRAS wild-type expressing colorectal cancer, cetuximab-based treatment added to first-line chemotherapy extended survival compared with use of bevacizumab-based treatment (See article on page 34).
- Suresh Ramalingam on the randomized GALAXY-1 study showing that ganetespib, a heat-shock protein inhibitor, improved the efficacy of chemotherapy in patients with advanced non-small-cell lung cancer.
- Emiel Rutgers on the final analysis of the EORTC AMAROS trial, showing that for breast cancer patients who have a positive sentinel node, radiotherapy is as effective as complete surgical axillary clearance and less toxic (See article on page 33).
- Also offering their expect commentary on each of the four studies, respectively: Lynn Schuchter, Richard Goldberg, Robert Pirker, and Pat Price.
To receive our iPad issues, download the free Oncology Times app from the App Store today! Visit http://bit.ly/OT-iPadApp , search in the App Store, or follow the link on oncology-times.com.